Literature DB >> 1702809

Transfer of polymorphic monoclonal antibody epitopes to the first and second domains of HLA-DR beta-chains by site-directed mutagenesis.

D Maurer1, J Gorski.   

Abstract

We used site-directed mutagenesis of HLA-DR beta-chains to localize the binding sites for two polymorphic DR-binding mAb to residues in the first and second external domains, respectively. Transfer of three first domain alpha-helical residues, G73, R74 and N77, normally present in DR3a and DRw52a, to a DR4 beta-chain was sufficient for recognition of this mutant DR molecule by a DR3-specific mAb, NDS 9. A polymorphism controlling the binding of a DR4-specific mAb, GS 359-13F10, was mapped to a tyrosine at position 96 of the DR4 beta-chain second domain by the construction fo a chimeric DR molecule containing a DR2-first domain and DR4-second domain. The mapping of these two polymorphic epitopes to specific positions on the DR beta-chain will allow further structural and functional analysis of the DR molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702809

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Molecular analysis of an HLA-DP mutant cell line selected for its resistance to killing by HLA-DPw2-specific T-cell clones.

Authors:  J Arroyo; R Díez-Orejas; A M Alvarez; S Shaw; M Sánchez-Pérez
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

2.  Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide.

Authors:  X T Fu; C P Bono; S L Woulfe; C Swearingen; N L Summers; F Sinigaglia; A Sette; B D Schwartz; R W Karr
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

3.  Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA-DR.

Authors:  Cynthia S M Kramer; Marry E I Franke-van Dijk; Kim H Bakker; Merve Uyar-Mercankaya; Gonca E Karahan; Dave L Roelen; Frans H J Claas; Sebastiaan Heidt
Journal:  Am J Transplant       Date:  2020-05-15       Impact factor: 8.086

4.  A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.

Authors:  E Mellins; P Cameron; M Amaya; S Goodman; D Pious; L Smith; B Arp
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.